The study to investigate effects of ezetimibe on the changes in plasma incretins
Not Applicable
- Conditions
- dyslipidemia
- Registration Number
- JPRN-UMIN000007225
- Lead Sponsor
- Department of Endocrinology, Diabetes and Geriatric Medicine, Akita University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. hypersensitivity to ezetimibe 2. patients with insulin, arufa-glucosidase inhibitor, biguanide or thiazolidinedione 3. patients with severe hepatic disease 4. patients with severe renal dysfunction 5. secondary hypercholesterolemia 6. familiar hypercholesterolemia 7. patients who are judged as inappropriate for this study by physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effects of ezetimibe on the changes in plasma incretins during meal tolerance test
- Secondary Outcome Measures
Name Time Method